
Aera VC
Description
Aera VC is a Singapore-based early-growth venture capital firm dedicated to investing in deep technology ventures that are pivotal in accelerating the world towards a sustainable future. The firm primarily targets companies at the Seed and Series A stages, providing crucial capital during their formative and scaling phases. Their investment thesis is centered around disruptive innovations across key sectors including Climate Tech, Food & Agri Tech, Industrial Tech, and Health Tech, all with a strong emphasis on environmental and societal impact.
The firm is known for its strategic approach to funding, typically deploying first cheques ranging from USD 1 million to USD 5 million. This substantial initial investment reflects their commitment to supporting capital-intensive deep tech solutions. Beyond the initial funding, Aera VC also reserves significant capital for follow-on rounds, demonstrating a long-term partnership approach with their portfolio companies. This ensures sustained support as these ventures mature and expand their operations.
Aera VC's portfolio showcases a diverse range of companies tackling global challenges. For instance, they have invested in firms like Carbon Clean, focusing on industrial carbon capture, and The EVERY Company, which develops animal-free protein solutions. Their commitment extends to fostering innovation in areas such as green hydrogen production with investments in SunGreenH2 and Supercritical, and advanced materials with companies like Novoloop, which specializes in plastic upcycling. This broad yet focused investment strategy underscores their mission to back technologies that offer scalable and impactful solutions for a more sustainable planet.
Investor Profile
Aera VC has backed more than 26 startups, with 2 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Pre Seed rounds (top funding stages).
- Majority of deals are located in United States, Australia, United Kingdom.
- Strong thematic focus on Biotechnology, Health Care, Alternative Protein.
- Typical check size: $1M – $5M.
Stage Focus
- Seed (62%)
- Series A (27%)
- Pre Seed (12%)
Country Focus
- United States (69%)
- Australia (12%)
- United Kingdom (4%)
- Singapore (4%)
- Canada (4%)
- New Zealand (4%)
Industry Focus
- Biotechnology
- Health Care
- Alternative Protein
- Artificial Intelligence (Ai)
- Software
- Manufacturing
- Food Processing
- Sustainability
- Genetics
- Life Science
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.